Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It has been classified differently according to its drug properties in which based on its chemical structure, gliclazide is considered a first-generation sulfonylurea due to the structural presence of a sulfonamide group able to release a ...
For the treatment of NIDDM in conjunction with diet and exercise.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.